OneMedNet Corp (ONMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on December 17, 2025, and December 23, 2025. The filing details the results of the Company's 2025 Annual Meeting of Stockholders and a subsequent Board of Directors appointment. OneMedNet Corporation is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes and Corporate Actions
- Annual Meeting Results: On December 17, 2025, the Company held its Annual Meeting with 40,710,355 shares represented (79.87% of outstanding shares), establishing a quorum.
- Director Elections: Stockholders approved the election of two Class II Directors for three-year terms expiring in 2028:
- Robert Golden: 30,232,405 votes FOR, 118,122 WITHHOLD, 10,359,828 BROKER NON-VOTES.
- Andrew Zeinfeld: 30,133,929 votes FOR, 216,598 WITHHOLD, 10,359,828 BROKER NON-VOTES.
- Auditor Ratification: Stockholders ratified the appointment of Withum Smith+Brown, PC as the independent registered public accounting firm for the year ending December 31, 2025.
- Votes: 40,698,469 FOR, 3,395 AGAINST, 8,491 ABSTAIN.
- Board Appointment: On December 23, 2025, the Board appointed Dr. Kenneth Alleyne to the Compensation Committee, replacing Jair Clarke whose term expired at the Annual Meeting.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document is limited to reporting the outcomes of the shareholder vote and the committee appointment.
Key Facts for Investor Verification
- Verify the continued tenure of the newly elected Class II Directors (Robert Golden and Andrew Zeinfeld) through 2028.
- Confirm the role of Dr. Kenneth Alleyne on the Compensation Committee and the departure of Jair Clarke.
- Note the high level of shareholder participation (79.87%) and the overwhelming support for the auditor ratification.
- Check subsequent filings (e.g., 10-K or 10-Q) for the actual financial performance data for the period ending December 31, 2025, as it is not included in this 8-K.